PhDD: A new pharmacophore-based de novo design method of drug-like molecules combined with assessment of synthetic accessibility
PhDD: A new pharmacophore-based de novo design method of drug-like molecules combined with assessment of synthetic accessibility is a paper indexed in PICO Portal from OpenAlex.
How many citations does PhDD: A new pharmacophore-based de novo design method of drug-like molecules combined with assessment of synthetic accessibility have?
PhDD: A new pharmacophore-based de novo design method of drug-like molecules combined with assessment of synthetic accessibility has 69 citations in the OpenAlex counts PICO Portal stores.
When was PhDD: A new pharmacophore-based de novo design method of drug-like molecules combined with assessment of synthetic accessibility published?
PhDD: A new pharmacophore-based de novo design method of drug-like molecules combined with assessment of synthetic accessibility has 2010 year in the PICO Portal index.
What is the open-access status of PhDD: A new pharmacophore-based de novo design method of drug-like molecules combined with assessment of synthetic accessibility?
PhDD: A new pharmacophore-based de novo design method of drug-like molecules combined with assessment of synthetic accessibility has closed oa status in the PICO Portal index.
What is the DOI of PhDD: A new pharmacophore-based de novo design method of drug-like molecules combined with assessment of synthetic accessibility?
The DOI for PhDD: A new pharmacophore-based de novo design method of drug-like molecules combined with assessment of synthetic accessibility is on the source record.
What is the PMID of PhDD: A new pharmacophore-based de novo design method of drug-like molecules combined with assessment of synthetic accessibility?
The PMID for PhDD: A new pharmacophore-based de novo design method of drug-like molecules combined with assessment of synthetic accessibility is on the source record.
What is the OpenAlex record for PhDD: A new pharmacophore-based de novo design method of drug-like molecules combined with assessment of synthetic accessibility?
The OpenAlex for PhDD: A new pharmacophore-based de novo design method of drug-like molecules combined with assessment of synthetic accessibility is on the source record.